Debut has secured $20 million in investment to accelerate the expansion of its proprietary, AI-based ingredient discovery platform to advance skin longevity innovation and scale its formulation business in the US and Asia.
Debut is building the future of beauty with cutting-edge AI and biotechnology, creating high-performing, innovative ingredients and formulations that propel the industry forward. The company specializes in scientifically-discovered, clinically-proven and inherently sustainable ingredients that provide maximum efficacy. Named one of the TIME100 Most Innovative Companies 2025, Debut is redefining the beauty industry's standards, centering on performance, potency and purity.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.